Archive · 17 Sep 2025
Mankind Pharma Partners with OpenAI for AI Integration
Mankind Pharma is teaming up with OpenAI to use smart computer programs (AI) to make their work better.
This includes everything from making medicines to talking with doctors.
They plan to use AI to make decisions faster, communicate more clearly, and even improve how they make products.
They have already started using AI tools to help their sales and marketing teams.
This means they can work smarter, faster, and hopefully help people more.
Mankind Pharma is partnering with OpenAI to integrate AI across its value chain.
The integration will affect areas like R&D, manufacturing, and marketing.
Custom GPTs have been deployed within Mankind Pharma since July 2025.
The goal is to improve decision-making and communication.
OpenAI's AI models, including GPT-5, will be utilized.
- Who
- Mankind Pharma and OpenAI
- What
- Collaborating to integrate AI across Mankind Pharma's value chain.
- When
- Since July 2025, and announced on September 17, 2025
- Where
- Across multiple functions within Mankind Pharma
- Why
- To improve efficiency, decision-making, and communication.
- Company
- Mankind Pharma
- Partner
- OpenAI
- Focus
- AI integration across value chain
- Date of Publication
- September 17, 2025
- Key Areas of Integration
- R&D, Manufacturing, Marketing, Supply Chain